ARYA Sciences Acquisition Corp IV | 10-Q/A: Quarterly report (Amendment)

SEC announcementMay 21 18:05 · Announcements

ARYA Sciences Acquisition Corp IV | 10-Q: Quarterly report

SEC announcementMay 21 05:26 · Announcements

Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider

MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ:GNTA), a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells to

GlobeNewswireMay 6 18:25

Adagio Medical to Go Public in $113M Deal With SPAC ARYA Sciences

Seeking AlphaFeb 14 22:13

Arya, Adagio Medical: Combined Company to Receive $42M From Equity, Convertible Note Investors at Closing >ARYD

Arya, Adagio Medical: Combined Company to Receive $42M From Equity, Convertible Note Investors at Closing >ARYD

Dow JonesFeb 14 19:08

Adagio Medical to List on Nasdaq Through Business Combination With ARYA Sciences Acquisition Corp IV >ARYD

Adagio Medical to List on Nasdaq Through Business Combination With ARYA Sciences Acquisition Corp IV >ARYD

Dow JonesFeb 14 19:07